Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Richmond

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|December 11, 2019
A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass IndexJason A Zell, Christine E McLaren, Timothy R Morgan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 27, 2025
A phase I dose escalation study of Polyphenon E in liver cirrhosis: Evaluation of safety and effect on liver γ-OHPdG levelsAiwu Ruth He, Coleman I Smith, Marcia Cruz-Correa, et al.
Gut|March 21, 2015
An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposisPatrick M Lynch, Carol A Burke, Robin Phillips, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2014
Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagusAmitabh Chak, Navtej S Buttar, Nathan R Foster, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2011
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemopreventionPaul J Limburg, Michelle R Mahoney, Katie L Allen Ziegler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 18, 2019
A Phase I Trial of Berberine in Chinese with Ulcerative ColitisLi Xu, Yujie Zhang, Xianmin Xue, et al.
Gut|May 31, 2022
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposisN Jewel Samadder, Nathan Foster, Ryan P McMurray, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 4, 2025
Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer ChemopreventionXiangzhu Zhu, Ruohui Chen, Reid M Ness, et al.
Gut|October 28, 2015
Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirinHemant K Roy, Vladimir Turzhitsky, Ramesh Wali, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 19, 2022
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) InfectionJeffrey M Jacobson, David Zahrieh, Carrie A Strand, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer Prevention Research (Philadelphia, Pa.)|December 11, 2019
A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass IndexJason A Zell, Christine E McLaren, Timothy R Morgan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 27, 2025
A phase I dose escalation study of Polyphenon E in liver cirrhosis: Evaluation of safety and effect on liver γ-OHPdG levelsAiwu Ruth He, Coleman I Smith, Marcia Cruz-Correa, et al.
Gut|March 21, 2015
An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposisPatrick M Lynch, Carol A Burke, Robin Phillips, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2014
Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagusAmitabh Chak, Navtej S Buttar, Nathan R Foster, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2011
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemopreventionPaul J Limburg, Michelle R Mahoney, Katie L Allen Ziegler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 18, 2019
A Phase I Trial of Berberine in Chinese with Ulcerative ColitisLi Xu, Yujie Zhang, Xianmin Xue, et al.
Gut|May 31, 2022
Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposisN Jewel Samadder, Nathan Foster, Ryan P McMurray, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 4, 2025
Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer ChemopreventionXiangzhu Zhu, Ruohui Chen, Reid M Ness, et al.
Gut|October 28, 2015
Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirinHemant K Roy, Vladimir Turzhitsky, Ramesh Wali, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 19, 2022
Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) InfectionJeffrey M Jacobson, David Zahrieh, Carrie A Strand, et al.
Pageof 4